EGFR-Mutated Lung Cancer With T790M-Acquired Resistance in the Brain and Histologic Transformation in the Lung

被引:31
|
作者
Scher, Kevin S. [1 ]
Saldivar, Juan-Sebastian [1 ]
Fishbein, Michael [2 ]
Marchevsky, Alberto [3 ]
Reckamp, Karen L. [1 ]
机构
[1] City Hope Comprehens Canc Ctr, Duarte, CA USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[3] Cedars Sinai Med Ctr, Hollywood, CA USA
关键词
ERLOTINIB; GEFITINIB;
D O I
10.6004/jnccn.2013.0126
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This case report describes the rare occurrence of a T790M resistance mutation found in a central nervous system (CNS) parenchymal metastasis. A concomitant squamous histology transformation in a lung non-T790M-resistant metastasis is also described. The authors hypothesize that this CNS resistance and histology transformation may have resulted from intermittent use of erlotinib treatment. This case report emphasizes the complexities of using erlotinib in the induction setting.
引用
收藏
页码:1040 / 1044
页数:5
相关论文
共 50 条
  • [41] Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer
    Matsumoto, Yoshiya
    Kawaguchi, Tomoya
    Watanabe, Masaru
    Isa, Shun-ichi
    Ando, Masahiko
    Tamiya, Akihiro
    Kubo, Akihito
    Kitagawa, Chiyoe
    Yoshimoto, Naoki
    Koh, Yasuhiro
    BMC CANCER, 2022, 22 (01)
  • [42] Osimertinib in EGFR T790M-Positive Lung Cancer
    Nishino, Mizuki
    Hatabu, Hiroto
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (20): : 1992 - 1993
  • [43] Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung Cancer
    Mambetsariev, Isa
    Arvanitis, Leonidas
    Fricke, Jeremy
    Pharaon, Rebecca
    Baroz, Angel R.
    Afkhami, Michelle
    Koczywas, Marianna
    Massarelli, Erminia
    Salgia, Ravi
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
  • [44] Exploration of Acquired Resistance Mechanisms to the 4th-Generation EGFR-TKI in EGFR-Mutated Lung Cancer - An in Vitro Study
    Fukuda, S.
    Suda, K.
    Hamada, A.
    Oiki, H.
    Ohara, S.
    Ito, M.
    Soh, J.
    Mitsudomi, T.
    Tsutani, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S455 - S455
  • [45] Small cell lung cancer transformation from EGFR-mutated lung adenocarcinoma: A case report and literatures review
    Liu, Yangyang
    CANCER BIOLOGY & THERAPY, 2018, 19 (06) : 445 - 449
  • [46] Squamous cell transformation as a mechanism of acquired resistance to tyrosine kinase inhibitor in EGFR-mutated lung adenocarcinoma: a report of two cases
    Uruga, Hironori
    Fujii, Takeshi
    Nakamura, Nobuyuki
    Moriguchi, Shuhei
    Kishi, Kazuma
    Takaya, Hisashi
    RESPIROLOGY CASE REPORTS, 2020, 8 (02):
  • [47] Acquired Resistance to Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer: How Do We Overcome It?
    Bertoli, Elisa
    De Carlo, Elisa
    Del Conte, Alessandro
    Stanzione, Brigida
    Revelant, Alberto
    Fassetta, Kelly
    Spina, Michele
    Bearz, Alessandra
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [48] Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-Mutated Non-small Cell Lung Cancer
    Lee, Jiyun
    Shim, Joon Ho
    Park, Woong-Yang
    Kim, Hee Kyung
    Sun, Jong-Mu
    Lee, Se-Noon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    CANCER RESEARCH AND TREATMENT, 2019, 51 (01): : 408 - 412
  • [49] Characterization of multiple driver alterations in acquired resistance to osimertinib in EGFR-mutated lung cancer: implementation of single cell approaches
    Chen, Jeanne
    Braye, Floriane
    Facchinetti, Francesco
    Lacroix, Ludovic
    Scoazec, Jean-Yves
    Tselikas, Lambros
    Planchard, David
    Mezquita, Laura
    Gazzah, Anas
    Naltet, Charles
    Lavaud, Pernelle
    Maillard, Aline
    Michiels, Stefan
    Massard, Christophe
    Olaussen, KenA
    Andr, Fabrice
    Vassal, Gilles
    Soria, Jean-Charles
    Besse, Benjamin
    Friboulet, Luc
    CANCER RESEARCH, 2020, 80 (16)
  • [50] Kinase Fusions as Recurrent Mechanisms of Acquired Resistance in EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)
    Ou, S.
    Klempner, S.
    Creelan, B.
    Hsieh, W. S.
    Costin, D.
    Stephens, P. J.
    Ross, J.
    Miller, V.
    Ali, S.
    Schrock, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1848 - S1848